Bruker (BRKR) Tops Q4 EPS by 1c, Offers Guidance

Go back to Bruker (BRKR) Tops Q4 EPS by 1c, Offers Guidance

Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 11, 2022 7:00 AM EST

Q4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy Q4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy FY 2021 revenues of $2.42B, up 21.7% yoy; organic revenue growth of 19.1% yoy FY 2021 GAAP EPS $1.81; non-GAAP EPS $2.10, up 55.6% yoy Solid organic revenue and non-GAAP EPS growth expected in FY 2022, with significant investments in Project Accelerate 2.0 initiatives, particularly in proteomics, spatial biology, semicon metrology and biopharma

BILLERICA, Mass.--(BUSINESS... More